Prospects for Antioxidant Therapy in Mild Cognitive Impairment and Alzheimer's Disease

Akihiko Nunomura; George Perry; Mark A. Smith

doi:10.1016/b978-044452809-4/50161-7

Related publications

Article2009

Sensorimotor network rewiring in mild cognitive impairment and Alzheimer's disease

Federica Agosta, Maria A. Rocca, Elisabetta Pagani, Martina Absinta, Giuseppe Magnani, Alessandra Marcone, Monica Falautano, Gıancarlo Comı, Maria Luisa Gorno‐Tempini, Massimo Filippi

Article2009

P3‐093: Motor network rewiring in mild cognitive impairment and Alzheimer's disease

Federica Agosta, Maria A. Rocca, Elisabetta Pagani, Martina Absinta, Giuseppe Magnani, Alessandra Marcone, Monica Falautano, Gıancarlo Comı, Maria Luisa Gorno‐Tempini, Massimo Filippi

Article2009

IC‐P‐061: Motor network rewiring in Mild Cognitive Impairment and Alzheimer's disease

Federica Agosta, Maria A. Rocca, Elisabetta Pagani, Martina Absinta, Giuseppe Magnani, Alessandra Marcone, Monica Falautano, Giacomo P. Comi, Maria Luisa Gorno‐Tempini, Massimo Filippi

Article2020

Conversion of Mild Cognitive Impairment to Alzheimer Disease in Monolingual and Bilingual Patients

Matthias Berkes, Ellen Bialystok, Fergus I. M. Craik, Angela K. Troyer, Morris Freedman

Alzheimer Disease & Associated Disorders

Article2010

Assessment of white matter tract damage in mild cognitive impairment and Alzheimer's disease

Michela Pievani, Federica Agosta, Elisabetta Pagani, Elisa Canu, Stefania Sala, Martina Absinta, Cristina Geroldi, Rossana Ganzola, Giovanni B. Frisoni, Massimo Filippi

Prospects for Antioxidant Therapy in Mild Cognitive Impairment and Alzheimer's Disease

Discussion(0)

Related publications

Sensorimotor network rewiring in mild cognitive impairment and Alzheimer's disease

P3‐093: Motor network rewiring in mild cognitive impairment and Alzheimer's disease

IC‐P‐061: Motor network rewiring in Mild Cognitive Impairment and Alzheimer's disease

Conversion of Mild Cognitive Impairment to Alzheimer Disease in Monolingual and Bilingual Patients

Assessment of white matter tract damage in mild cognitive impairment and Alzheimer's disease